MDM2 and breast carcinoma: In the present study, after demonstration of its anti-breast cancer activity in vivo, we attempted to explore the molecular mechanisms for the effects of 25-OCH3-PPD on both primary and metastatic breast cancers, showing MDM2 to be a major target.